There was strong buying activity in Valereum (LON: VLRM) shares even though there was no news. There were around 3.5 million shares traded during the week with Thursday the most active day. The share price jumped 108% to 6.75p.
SulNOx Group (LON: SNOX) increased revenues from £203,000 to £544,000, but the loss was still around £1.9m. Cash was £2.15m at the end of June 2024. A generator-based study for the SulNOxEco fuel additive shows fuel savings of 15%. The share price rose 17.7% to 36.5p.
The increase in the value of the 15% stake held by Global Connectivity (LON: GCON) lead to the July 2024 rising from £7.8m to £17.2m in a six-month period. That is 4.25p/share. The share price improved 10.2% to 1.625p.
Investment company EPE Special Opportunities Ltd (LON: EO.P) reported a reduced loss because there was a gain on fair value movements on investments compared with a loss last time. There was cash of £18.4m at the end of July 2024. NAV was 319p/share at the end of July and it fell back to 314p/share by the end of August. The share price edged up 3.23% to 160p.
FALLERS
Warrants held by lupus treatment developer ImmuPharma (LON: IMM) to subscribe for shares in Incanthera (LON: INC) at 9.5p each have been extended to the end of March 2025 in return for a £75,0000 payment by ImmuPharma. The share price declined 15.8% to 24p.
Exchange services provider Aquis Exchange (LON: AQX), which is also quoted on the Aquis Stock Exchange, has already warned that the loss of a software contract will hit revenues this year. Net interim revenues were still 4% ahead at £10m. Pre-tax profit was 8% lower at £1.1m. There was a small dip in revenues of the core exchange division. Net cash was £14.5m at the end of June 2024. There are plans to increase investment in technology to increase the addressable market, so year-end cash will be slightly lower than expected at £15.1m. The share price fell a further 1.28% to 385p.